Breast Cancer Research | Articles which cite: The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G, Bendahl PO, Ringnér M, Saal LH, Gruvberger-Saal SK, Lövgren K, Grabau D, Fernö M, Borg A, Hegardt C
Breast Cancer Res 2008, 10:R53
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

BioMed Central articles that cite the above article:

Research article

Research article

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Puppe J, Drost R, Liu X, Joosse SA, Evers B, Cornelissen-Steijger P, Nederlof P, Yu Q, Jonkers J, van Lohuizen M, Pietersen AM
Breast Cancer Research 2009, 11:R63 (26 August 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

Review

Breast cancer stem cells: tools and models to rely on
Charafe-Jauffret E, Ginestier C, Birnbaum D
BMC Cancer 2009, 9:202 (25 June 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Viewpoint

Number crunching in the cancer stem cell market
Alison MR, Islam S, Lim SML
Breast Cancer Research 2009, 11:302 (24 April 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

Editorial

Review

Breast cancer stem cells: implications for therapy of breast cancer
Morrison BJ, Schmidt CW, Lakhani SR, Reynolds BA, Lopez JA
Breast Cancer Research 2008, 10:210 (22 July 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 5 articles in PubMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]